Company Filing History:
Years Active: 2017-2020
Title: Emine Sahin-Heco: Innovator in Immune Modulation
Introduction
Emine Sahin-Heco is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of immunology, particularly through her innovative methods and compositions for modulating the immune system. With a total of 3 patents, her work is paving the way for advancements in treating immune disorders and improving transplant outcomes.
Latest Patents
Emine's latest patents focus on the use of recombinant Arginase I proteins. These proteins are capable of depleting plasma arginine levels in a subject, which can modulate the activity of the immune system. This modulation is particularly useful in treating immune disorders and preventing the rejection of transplanted organs, tissues, or cells. Additionally, her methods and compositions can also be applied to treat bone conditions in subjects.
Career Highlights
Emine Sahin-Heco is associated with Bio-Cancer Treatment International Limited, where she continues to develop her groundbreaking research. Her work is characterized by a commitment to improving patient outcomes through innovative therapeutic strategies.
Collaborations
Emine collaborates with notable professionals in her field, including Gernot Schabbauer and Paul Cheng. These collaborations enhance her research and contribute to the advancement of immunological therapies.
Conclusion
Emine Sahin-Heco's contributions to the field of immunology through her patents and research are invaluable. Her innovative approaches to immune modulation hold great promise for the future of medical treatments.